These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14999438)

  • 1. Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.
    Reder-Hilz B; Ullrich M; Ringel M; Hewitt N; Utesch D; Oesch F; Hengstler JG
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Apr; 369(4):408-17. PubMed ID: 14999438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of [
    Nallani GC; ElNaggar SF; Shen L; Chandrasekaran A
    Regul Toxicol Pharmacol; 2017 Mar; 84():26-34. PubMed ID: 27993653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures.
    Hewitt NJ; Bühring KU; Dasenbrock J; Haunschild J; Ladstetter B; Utesch D
    Drug Metab Dispos; 2001 Jul; 29(7):1042-50. PubMed ID: 11408372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of verapamil: 24 new phase I and phase II metabolites identified in cell cultures of rat hepatocytes by liquid chromatography-tandem mass spectrometry.
    Walles M; Thum T; Levsen K; Borlak J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):265-74. PubMed ID: 14643506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction.
    Hengstler JG; Utesch D; Steinberg P; Platt KL; Diener B; Ringel M; Swales N; Fischer T; Biefang K; Gerl M; Böttger T; Oesch F
    Drug Metab Rev; 2000 Feb; 32(1):81-118. PubMed ID: 10711408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference of metabolic clearance of bisphenol A using cryopreserved hepatocytes from rats, monkeys and humans.
    Kurebayashi H; Okudaira K; Ohno Y
    Toxicol Lett; 2010 Oct; 198(2):210-5. PubMed ID: 20599483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the metabolism of propranolol by linear ion trap technology in mouse, rat, dog, monkey, and human cryopreserved hepatocytes.
    Baughman TM; Talarico CL; Soglia JR
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2146-50. PubMed ID: 19517456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and determination of phase I metabolites of propafenone in rat liver perfusate.
    Tan W; Li Q; McKay G; Semple HA
    J Pharm Biomed Anal; 1998 Feb; 16(6):991-1003. PubMed ID: 9547702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
    Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
    Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human.
    Carmo H; Hengstler JG; de Boer D; Ringel M; Remião F; Carvalho F; Fernandes E; dos Reys LA; Oesch F; de Lourdes Bastos M
    Toxicology; 2005 Jan; 206(1):75-89. PubMed ID: 15590110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6.
    Dilger K; Greiner B; Fromm MF; Hofmann U; Kroemer HK; Eichelbaum M
    Pharmacogenetics; 1999 Oct; 9(5):551-9. PubMed ID: 10591535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective glucuronidation of propafenone and its analogues by human recombinant UGT1A9.
    Xie S; Zeng S
    Chem Pharm Bull (Tokyo); 2010 Jun; 58(6):879-83. PubMed ID: 20523006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism of a new cardioprotective agent, KR-33028 in the human liver microsomes and cryopreserved human hepatocytes.
    Kim H; Yoon YJ; Kim H; Cha EY; Lee HS; Kim JH; Yi KY; Lee S; Cheon HG; Yoo SE; Lee SS; Shin JG; Liu KH
    Arch Pharm Res; 2005 Nov; 28(11):1287-92. PubMed ID: 16350857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear pharmacokinetics of propafenone in rats and humans: application of a substrate depletion assay using hepatocytes for assessment of nonlinearity.
    Komura H; Iwaki M
    Drug Metab Dispos; 2005 Jun; 33(6):726-32. PubMed ID: 15743979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which hydroxy? Evidence for species differences in the regioselectivity of glucuronidation in rat, dog, and human in vitro systems and dog in vivo.
    Martin IJ; Lewis RJ; Bernstein MA; Beattie IG; Martin CA; Riley RJ; Springthorpe B
    Drug Metab Dispos; 2006 Sep; 34(9):1502-7. PubMed ID: 16763016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro metabolism of 14C-ciclesonide in hepatocytes from the mouse, rat, rabbit, dog, and human.
    Gu Z; Zhao XG; Nave R; Liu DD; Feng H; Wu J; Howell SR; Guo Z
    Am J Ther; 2007; 14(3):280-90. PubMed ID: 17515705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.
    Carmo H; Hengstler JG; de Boer D; Ringel M; Carvalho F; Fernandes E; Remião F; dos Reys LA; Oesch F; de Lourdes Bastos M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Feb; 369(2):198-205. PubMed ID: 14676987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral metabolism of propafenone in rat hepatic microsomes treated with two inducers.
    Zhou Q; Yao TW; Zeng S
    World J Gastroenterol; 2001 Dec; 7(6):830-5. PubMed ID: 11854911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.